Dr. Roland Miles Glassman, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 407 Riverway Pl, Bedford, NH 03110 Phone: 603-668-3772 Fax: 603-668-2786 |
Dr. William D Foord, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 60 Pleasant St, Berlin, NH 03570 Phone: 603-752-2237 Fax: 603-752-2868 |
Carol F. Boerner, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 130 Pleasant St, Claremont, NH 03743 Phone: 603-542-2002 |
Maynard B Wheeler, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 248 Pleasant Street, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
Maxwell Arrington Snead Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 |
Dr. Tighe Curtis Richardson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-7061 |
Andre A D'hemecourt, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 |
Christie L Morse, MD Ophthalmology - Pediatric Ophthalmology and Strabismus Specialist Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
David Alan Weinberg, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 1600, Concord Eye Care, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
Bradford S Hall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Ste 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
Catherine Marando, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 248 Pleasant St Ste 1600, Concord, NH 03301 Phone: 603-224-2020 |
Thomas Gordon Hand, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 248 Pleasant St, Ste 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-227-9992 |
Erin S Fogel, M.D. Ophthalmology - Cornea and External Diseases Specialist Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 |
Paul G Degregorio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-7061 |
Eliot D Foley, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
Mark A Szal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |
Olga Stetsyuk, DO Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 1600, Concord, NH 03301 Phone: 603-224-2020 |
Brett Lowell Smith, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-7061 |
Lloyd M Wilcox, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 |
Dr. Tahsin Khundkar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-415-5519 |
News Archive
Model G - the new Detroit-designed hospital gown that finally closes the drafty, embarrassing backside - has moved from creative concept to the patient's bedside, with more than 35,000 gowns rolling out this month throughout Henry Ford Health System's hospitals.
An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness Research Center at Yale Cancer Center.
Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.
Two new studies report specific mechanisms of impaired type I interferon (IFN) signaling in some hospitalized patients suffering from severe cases of COVID-19, suggesting that screens for these defects could help identify patients at the highest risk of life-threatening complications from SARS-CoV-2 infection.
Preeclampsia is globally a leading cause of illness and deaths among mothers and their babies. This severe pregnancy disorder occurs in up to five percent of all pregnancies.
› Verified 6 days ago